Scandinavian Medical Solutions (One-pager): Building the foundation for the next growth phase
We have updated our investment case one-pager following Scandinavian Medical Solutions’ H1 2023/24 report which was announced last week.
In the first half of the accounting year 2023/24, Scandinavian Medical Solutions reported revenue of DKK 102.6 million, corresponding to a growth of approximately 7% YoY. Looking at profitability, however, frontloaded investments to build the foundation for the next growth phase meant that EBITDA declined significantly to DKK 8.0m (DKK 14.4m in H1 2022/23). The decline is primarily driven by the growth investments, also shown by a gross margin that only fell marginally.
The company reiterated its full-year 2023/24 guidance with revenue expected to be between DKK 210-230m and EBITDA between DKK 20-23m.
For further details about the H1 2023/24 results, you can watch the management presentation with CEO Jens Hvid Paulsen and Head of Sales Martin Lind here: https://www.inderes.dk/videos/scandinavian-medical-solutions-praesentation-af-h1-20232024
Disclaimer: HC Andersen Capital receives payment from Scandinavian Medical Solutions for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis 15:30, 21 May 2024.
Scandinavian Medical Solutions
Scandinavian Medical Solutions är verksamt inom vård och omsorg. Bolaget är en dansk återförsäljare av bilddiagnostikutrustning. Produktutbudet inkluderar CT- och MR-skannrar samt ultraljudsenheter och röntgenutrustning. Bolaget bedriver sin försäljning globalt och kunderna återfinns främst bland sjukhus. Scandinavian Medical Solutions grundades 2019 och har sitt huvudkontor i Aalborg.
Read more on company page